1. Home
  2. ICCC vs REFR Comparison

ICCC vs REFR Comparison

Compare ICCC & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$6.27

Market Cap

55.5M

Sector

Health Care

ML Signal

N/A

Logo Research Frontiers Incorporated

REFR

Research Frontiers Incorporated

HOLD

Current Price

$1.27

Market Cap

54.8M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
REFR
Founded
1982
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
55.5M
54.8M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
ICCC
REFR
Price
$6.27
$1.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.5K
52.0K
Earning Date
02-25-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$27,769,304.00
$1,227,276.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.27
N/A
Revenue Growth
16.49
N/A
52 Week Low
$4.28
$0.93
52 Week High
$7.60
$2.70

Technical Indicators

Market Signals
Indicator
ICCC
REFR
Relative Strength Index (RSI) 52.97 37.26
Support Level $6.15 $1.21
Resistance Level $6.92 $1.32
Average True Range (ATR) 0.33 0.08
MACD -0.05 0.01
Stochastic Oscillator 31.82 16.62

Price Performance

Historical Comparison
ICCC
REFR

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

Share on Social Networks: